Evaluating usefulness of ING1 expression in stroma as a prognostic biomarker in breast cancer.

被引：0
|
作者：
Nabbi, Arash
Thakur, Satbir
Klimowicz, Alexander C.
Riabowol, Karl
机构：
[1] Univ Calgary, Calgary, AB, Canada
[2] Univ Calgary, Tom Baker Canc Ctr, Dept Oncol, Calgary, AB, Canada
[3] Univ Calgary, Dept Pathol, Tom Baker Canc Ctr, Calgary, AB, Canada
[4] Univ Calgary, Dept Lab Med, Tom Baker Canc Ctr, Calgary, AB, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e11543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e11543
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Clinical usefulness of ATBF1-A expression in breast cancer as a prognostic and predictive marker
    不详
    EJC SUPPLEMENTS, 2006, 4 (02): : 145 - 145
  • [22] Significance of FAP, SMA and CD31 Expression in the Stroma of Breast Cancer.
    Tchou, J.
    Satija, C.
    Zhang, P.
    Bi, Y.
    Davuluri, R.
    Chen, H.
    Majumdar, R.
    Mies, C.
    Herlyn, M.
    Pure, E.
    CANCER RESEARCH, 2011, 71
  • [23] Tenascin expression in cancer cells and stroma of human breast cancer and its prognostic significance
    Ishihara, A
    Yoshida, T
    Tamaki, H
    Sakakura, T
    CLINICAL CANCER RESEARCH, 1995, 1 (09) : 1035 - 1041
  • [24] β1 integrin expression is prognostic for overall and disease-free survival in breast cancer.
    Yao, ES
    Lee, B
    Chen, YY
    Moore, DH
    Chew, K
    Park, CC
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S135 - S135
  • [25] A novel prognostic immunohistochemical biomarker panel for estrogen receptor expressing breast cancer.
    Ross, DT
    Ring, BZ
    Seitz, RS
    Beck, R
    Shasteen, WJ
    Tarr, SM
    Cheang, MC
    Yoder, BJ
    Budd, GT
    Nielsen, TO
    Hicks, DG
    Estopinal, NC
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S124 - S125
  • [26] Usefulness of evaluating neoangiogenesis in breast cancer
    Namer, M
    Ettore, F
    Pivot, X
    Ferrero, JM
    Teissier, E
    BULLETIN DU CANCER, 1996, 83 (12) : 1041 - 1042
  • [27] Bromodomain-containing protein 7 as tumour suppressor and prognostic biomarker in breast cancer.
    Lo Nigro, Cristiana
    Garrone, Ornella
    Vivenza, Daniela
    Brizio, Rodolfo
    Mantovani, Fiamma
    Del Sal, Giannino
    Merlano, Marco Carlo
    Crook, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Expression of p33/ING1 gene products in colorectal cancer and its correlation with survival.
    Ahmed, IAM
    Nouman, GS
    Lunec, J
    Kelly, SB
    Anderson, JJ
    Angus, B
    GASTROENTEROLOGY, 2001, 120 (05) : A300 - A300
  • [29] Loss of CD63 expression as a prognostic marker in breast cancer.
    Shaw, LE
    Seery, LT
    Nicholson, RI
    Darbre, PD
    BREAST CANCER RESEARCH AND TREATMENT, 2001, 69 (03) : 296 - 296
  • [30] NDRG1 is a prognostic biomarker in breast cancer and breast cancer brain metastasis
    Joshi, Vaibhavi
    Stacey, Andrew
    Feng, Yufan
    Kalita-de Croft, Priyakshi
    Duijf, Pascal H. G.
    Simpson, Peter T.
    Lakhani, Sunil R.
    Reed, Amy E. McCart
    JOURNAL OF PATHOLOGY CLINICAL RESEARCH, 2024, 10 (02):
12345